Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease

Objective: Predicted age difference (PAD) is a score computed by subtracting chronological age from “brain” age, which is estimated using neuroimaging data. The goal of this study was to evaluate the PAD as a marker of phenotypic heterogeneity and severity among early-onset Alzheimer's disease...

Full description

Bibliographic Details
Main Authors: Morgan Gautherot, Grégory Kuchcinski, Cécile Bordier, Adeline Rollin Sillaire, Xavier Delbeuck, Mélanie Leroy, Xavier Leclerc, Jean-Pierre Pruvo, Florence Pasquier, Renaud Lopes
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.729635/full
_version_ 1818900767307726848
author Morgan Gautherot
Grégory Kuchcinski
Grégory Kuchcinski
Grégory Kuchcinski
Cécile Bordier
Adeline Rollin Sillaire
Adeline Rollin Sillaire
Xavier Delbeuck
Mélanie Leroy
Mélanie Leroy
Xavier Leclerc
Xavier Leclerc
Xavier Leclerc
Jean-Pierre Pruvo
Jean-Pierre Pruvo
Jean-Pierre Pruvo
Florence Pasquier
Florence Pasquier
Florence Pasquier
Renaud Lopes
Renaud Lopes
author_facet Morgan Gautherot
Grégory Kuchcinski
Grégory Kuchcinski
Grégory Kuchcinski
Cécile Bordier
Adeline Rollin Sillaire
Adeline Rollin Sillaire
Xavier Delbeuck
Mélanie Leroy
Mélanie Leroy
Xavier Leclerc
Xavier Leclerc
Xavier Leclerc
Jean-Pierre Pruvo
Jean-Pierre Pruvo
Jean-Pierre Pruvo
Florence Pasquier
Florence Pasquier
Florence Pasquier
Renaud Lopes
Renaud Lopes
author_sort Morgan Gautherot
collection DOAJ
description Objective: Predicted age difference (PAD) is a score computed by subtracting chronological age from “brain” age, which is estimated using neuroimaging data. The goal of this study was to evaluate the PAD as a marker of phenotypic heterogeneity and severity among early-onset Alzheimer's disease (EOAD) patients.Methods: We first used 3D T1-weighted (3D-T1) magnetic resonance images (MRI) of 3,227 healthy subjects aged between 18 and 85 years to train, optimize, and evaluate the brain age model. A total of 123 participants who met the criteria for early-onset (<65 years) sporadic form of probable Alzheimer's disease (AD) and presented with two distinctive clinical presentations [an amnestic form (n = 74) and a non-amnestic form (n = 49)] were included at baseline and followed-up for a maximum period of 4 years. All the participants underwent a work-up at baseline and every year during the follow-up period, which included clinical examination, neuropsychological testing and genotyping, and structural MRI. In addition, cerebrospinal fluid biomarker assay was recorded at baseline. PAD score was calculated by applying brain age model to 3D-T1 images of the EOAD patients and healthy controls, who were matched based on age and sex. At baseline, between-group differences for neuropsychological and PAD scores were assessed using linear models. Regarding longitudinal analysis of neuropsychological and PAD scores, differences between amnestic and non-amnestic participants were analyzed using linear mixed-effects modeling.Results: PAD score was significantly higher for non-amnestic patients (2.35 ± 0.91) when compared to amnestic patients (2.09 ± 0.74) and controls (0.00 ± 1). Moreover, PAD score was linearly correlated with the Mini-Mental State Examination (MMSE) and the Clinical Dementia Rating Sum of Boxes (CDR-SB), for both amnestic and non-amnestic sporadic forms. Longitudinal analyses showed that the gradual development of the disease in patients was accompanied by a significant increase in PAD score over time, for both amnestic and non-amnestic patients.Conclusion: PAD score was able to separate amnestic and non-amnestic sporadic forms. Regardless of the clinical presentation, as PAD score was a way of quantifying an early brain age acceleration, it was an appropriate method to detect the development of AD and follow the evolution of the disease as a marker of severity as MMSE and CDR-SB.
first_indexed 2024-12-19T20:09:05Z
format Article
id doaj.art-45e242480d8447318a806c0756b17458
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-19T20:09:05Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-45e242480d8447318a806c0756b174582022-12-21T20:07:22ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652021-11-011310.3389/fnagi.2021.729635729635Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's DiseaseMorgan Gautherot0Grégory Kuchcinski1Grégory Kuchcinski2Grégory Kuchcinski3Cécile Bordier4Adeline Rollin Sillaire5Adeline Rollin Sillaire6Xavier Delbeuck7Mélanie Leroy8Mélanie Leroy9Xavier Leclerc10Xavier Leclerc11Xavier Leclerc12Jean-Pierre Pruvo13Jean-Pierre Pruvo14Jean-Pierre Pruvo15Florence Pasquier16Florence Pasquier17Florence Pasquier18Renaud Lopes19Renaud Lopes20UMS 2014–US 41–PLBS–Plateformes Lilloises en Biologie & Santé, University of Lille, Lille, FranceUMS 2014–US 41–PLBS–Plateformes Lilloises en Biologie & Santé, University of Lille, Lille, FranceInserm, U1172–LilNCog–Lille Neuroscience & Cognition, University of Lille, Lille, FranceNeuroradiology Department, Lille University Medical Centre, Lille, FranceInserm, U1172–LilNCog–Lille Neuroscience & Cognition, University of Lille, Lille, FranceMemory Center, DISTALZ, Lille, FranceNeurology Department, Lille University Medical Centre, Lille, FranceMemory Center, DISTALZ, Lille, FranceInserm, U1172–LilNCog–Lille Neuroscience & Cognition, University of Lille, Lille, FranceMemory Center, DISTALZ, Lille, FranceUMS 2014–US 41–PLBS–Plateformes Lilloises en Biologie & Santé, University of Lille, Lille, FranceInserm, U1172–LilNCog–Lille Neuroscience & Cognition, University of Lille, Lille, FranceNeuroradiology Department, Lille University Medical Centre, Lille, FranceUMS 2014–US 41–PLBS–Plateformes Lilloises en Biologie & Santé, University of Lille, Lille, FranceInserm, U1172–LilNCog–Lille Neuroscience & Cognition, University of Lille, Lille, FranceNeuroradiology Department, Lille University Medical Centre, Lille, FranceInserm, U1172–LilNCog–Lille Neuroscience & Cognition, University of Lille, Lille, FranceMemory Center, DISTALZ, Lille, FranceNeurology Department, Lille University Medical Centre, Lille, FranceUMS 2014–US 41–PLBS–Plateformes Lilloises en Biologie & Santé, University of Lille, Lille, FranceInserm, U1172–LilNCog–Lille Neuroscience & Cognition, University of Lille, Lille, FranceObjective: Predicted age difference (PAD) is a score computed by subtracting chronological age from “brain” age, which is estimated using neuroimaging data. The goal of this study was to evaluate the PAD as a marker of phenotypic heterogeneity and severity among early-onset Alzheimer's disease (EOAD) patients.Methods: We first used 3D T1-weighted (3D-T1) magnetic resonance images (MRI) of 3,227 healthy subjects aged between 18 and 85 years to train, optimize, and evaluate the brain age model. A total of 123 participants who met the criteria for early-onset (<65 years) sporadic form of probable Alzheimer's disease (AD) and presented with two distinctive clinical presentations [an amnestic form (n = 74) and a non-amnestic form (n = 49)] were included at baseline and followed-up for a maximum period of 4 years. All the participants underwent a work-up at baseline and every year during the follow-up period, which included clinical examination, neuropsychological testing and genotyping, and structural MRI. In addition, cerebrospinal fluid biomarker assay was recorded at baseline. PAD score was calculated by applying brain age model to 3D-T1 images of the EOAD patients and healthy controls, who were matched based on age and sex. At baseline, between-group differences for neuropsychological and PAD scores were assessed using linear models. Regarding longitudinal analysis of neuropsychological and PAD scores, differences between amnestic and non-amnestic participants were analyzed using linear mixed-effects modeling.Results: PAD score was significantly higher for non-amnestic patients (2.35 ± 0.91) when compared to amnestic patients (2.09 ± 0.74) and controls (0.00 ± 1). Moreover, PAD score was linearly correlated with the Mini-Mental State Examination (MMSE) and the Clinical Dementia Rating Sum of Boxes (CDR-SB), for both amnestic and non-amnestic sporadic forms. Longitudinal analyses showed that the gradual development of the disease in patients was accompanied by a significant increase in PAD score over time, for both amnestic and non-amnestic patients.Conclusion: PAD score was able to separate amnestic and non-amnestic sporadic forms. Regardless of the clinical presentation, as PAD score was a way of quantifying an early brain age acceleration, it was an appropriate method to detect the development of AD and follow the evolution of the disease as a marker of severity as MMSE and CDR-SB.https://www.frontiersin.org/articles/10.3389/fnagi.2021.729635/fullbrain agedeep learningstructural MRIlongitudinal analysisearly-onset Alzheimer's diseasephenotypic variants
spellingShingle Morgan Gautherot
Grégory Kuchcinski
Grégory Kuchcinski
Grégory Kuchcinski
Cécile Bordier
Adeline Rollin Sillaire
Adeline Rollin Sillaire
Xavier Delbeuck
Mélanie Leroy
Mélanie Leroy
Xavier Leclerc
Xavier Leclerc
Xavier Leclerc
Jean-Pierre Pruvo
Jean-Pierre Pruvo
Jean-Pierre Pruvo
Florence Pasquier
Florence Pasquier
Florence Pasquier
Renaud Lopes
Renaud Lopes
Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease
Frontiers in Aging Neuroscience
brain age
deep learning
structural MRI
longitudinal analysis
early-onset Alzheimer's disease
phenotypic variants
title Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease
title_full Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease
title_fullStr Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease
title_full_unstemmed Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease
title_short Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease
title_sort longitudinal analysis of brain predicted age in amnestic and non amnestic sporadic early onset alzheimer s disease
topic brain age
deep learning
structural MRI
longitudinal analysis
early-onset Alzheimer's disease
phenotypic variants
url https://www.frontiersin.org/articles/10.3389/fnagi.2021.729635/full
work_keys_str_mv AT morgangautherot longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT gregorykuchcinski longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT gregorykuchcinski longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT gregorykuchcinski longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT cecilebordier longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT adelinerollinsillaire longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT adelinerollinsillaire longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT xavierdelbeuck longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT melanieleroy longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT melanieleroy longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT xavierleclerc longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT xavierleclerc longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT xavierleclerc longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT jeanpierrepruvo longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT jeanpierrepruvo longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT jeanpierrepruvo longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT florencepasquier longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT florencepasquier longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT florencepasquier longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT renaudlopes longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease
AT renaudlopes longitudinalanalysisofbrainpredictedageinamnesticandnonamnesticsporadicearlyonsetalzheimersdisease